Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Early research (Phase 1)WithdrawnNCT03275792
What this trial is testing

Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion

Who this might be right for
Hemolytic-Uremic Syndrome
University of Calgary
Not applicableStudy completedNCT01406288
What this trial is testing

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4

Who this might be right for
Hemolytic-uremic SyndromeEscherichia Coli Infections
University Hospital, Bordeaux 9
Testing effectiveness (Phase 2)Study completedNCT05569746
What this trial is testing

Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS

Who this might be right for
Diarrhea-Associated Hemolytic Uremic SyndromePediatric Kidney DiseaseHemolytic-Uremic Syndrome
Inmunova S.A. 57
Not applicableLooking for participantsNCT05219110
What this trial is testing

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Who this might be right for
Shiga Toxin-Producing Escherichia Coli (E. Coli) InfectionHemolytic-Uremic Syndrome
University of Calgary 1,040
Testing effectiveness (Phase 2)Study completedNCT01252199
What this trial is testing

Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2

Who this might be right for
Shiga Toxin Producing Bacterial Infection
Thallion Pharmaceuticals 45